Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2007
09/26/2007EP1836183A2 Spiro derivatives as lipoxygenase inhibitors
09/26/2007EP1836180A2 Sulfonyl pyrrolidines, method for producing the same and their use as drugs
09/26/2007EP1836179A1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
09/26/2007EP1836176A1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEROF
09/26/2007EP1836172A1 5-ht7 receptor antagonists
09/26/2007EP1836166A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
09/26/2007EP1836165A1 Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases
09/26/2007EP1836164A1 11c-labeled benzyl-lactam compounds and their use as imaging agents
09/26/2007EP1836163A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
09/26/2007EP1687293B1 Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1)
09/26/2007EP1474416B1 Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders
09/26/2007EP1458708B1 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5
09/26/2007EP1451153B1 Nk1 antagonists
09/26/2007EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
09/26/2007EP1337150A4 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
09/26/2007EP1302461B1 Tnf-alpha production inhibitors
09/26/2007EP1276732B1 Amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation"
09/26/2007EP1263726B1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa
09/26/2007EP1261585B1 Substituted indole mannich bases
09/26/2007EP1194447B1 Novel potassium channels and genes encoding these potassium channels
09/26/2007EP1154998B1 Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy
09/26/2007CN101044138A Methods for preparing indazole compounds
09/26/2007CN101044135A 喹啉衍生物 Quinoline derivatives
09/26/2007CN101044134A Azaspiroalkene and azapiroalkane compounds with nicotinic cholinergic receptor activity
09/26/2007CN101044123A Pyrimidine derivative fused with nonaromatic ring
09/26/2007CN101044121A 4-aminopyrimidine-5-one
09/26/2007CN101044116A 4-phenylsulfonamidopiperidines as calcium channel blockers
09/26/2007CN101044115A Piperidines and related compounds for treatment of alzheimer's disease
09/26/2007CN101044113A Substituted indole compounds, their preparation and use in medicaments
09/26/2007CN101041669A Non nucleoside reverse transcriptase inhibitors
09/26/2007CN101041634A 3-substituted chinoline derivative and method for synthesizing same
09/26/2007CN100339376C Nitrogen-containing aromatic ring derivatives
09/26/2007CN100339352C 2-and 2,5-substituted phenylketoenols
09/26/2007CN100339080C Antiviral compounds
09/25/2007US7273940 Complex with iron, cobalt; polymerization of alpha-olefins, cyclic olefin
09/25/2007US7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
09/25/2007US7273882 Aminoacetamide acyl guanidines as β-secretase inhibitors
09/25/2007US7273878 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
09/25/2007US7273877 5-substituted-4-[(substituted phenyl) amino]-2-pyridone derivatives
09/25/2007US7273869 P-(aminomethyl)phenyl-substituted pyrazoloquinoxalines, imidazoquinoxalines, triazoloquinoxalines and benzoquinoxalines, e.g., N,N-dimethyl-1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methanamine; serine/threonine protein kinase inhibitors for treating cancer
09/25/2007US7273868 excellent phosphodiesterase V (PDE V) inhibitory activity, and being useful as a remedy for the prophylaxis or treatment of penile erectile dysfunction with few side effects
09/25/2007US7273867 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents
09/25/2007US7273863 Benzophenones as inhibitors of reverse transcriptase
09/25/2007US7273857 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes
09/25/2007CA2389766C New indenoindolone derivatives, the procedure for preparing them and the pharmaceutical compounds that contain them
09/25/2007CA2267928C Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides
09/25/2007CA2243317C Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands
09/20/2007WO2007106705A1 Soluble epoxide hydrolase inhibitors and methods of using same
09/20/2007WO2007106525A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases
09/20/2007WO2007106022A2 A new crystalline form g of (5s) -5- [4- (5-chloro-pyridin-2- yloxy) -piperidine-1-sulfonylmethyl] - 5 -methyl -imidazolidine - 2,4-dione (i) and intermediates thereof.
09/20/2007WO2007105989A2 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library
09/20/2007WO2007105766A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
09/20/2007WO2007105753A1 Triazole derivative or salt thereof
09/20/2007WO2007105751A1 Quinolone derivative or pharmaceutically acceptable salt thereof
09/20/2007WO2007105637A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
09/20/2007WO2007105551A1 Novel pyridine derivative having anti-helicobacter pylori activity
09/20/2007WO2007105058A2 Pyrazole compounds
09/20/2007WO2007105053A2 Tetralines antagonists of the h-3 receptor
09/20/2007WO2007105049A1 Dibenzyl amine derivatives as cetp inhibitors
09/20/2007WO2007104783A2 1,4 -di substituted 3-cyano-pyridone derivatives and their use as positive mglur2-recept0r modulators
09/20/2007WO2007104696A1 Antimalarial agents having polyaromatic structure
09/20/2007WO2007104695A1 Quinolin-4-ylhydrazine derivatives as antimalarial agent
09/20/2007WO2007104652A2 Non-peptidic renin inhibitors nitroderivatives
09/20/2007WO2007104560A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs
09/20/2007WO2007104538A1 Heterobicyclic carboxamides as inhibitors for kinases
09/20/2007WO2007104162A1 Iap bir domain binding compounds
09/20/2007WO2007089768A3 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
09/20/2007WO2007085557A3 Use of substituted 2-imidazole of imidazoline derivatives
09/20/2007WO2007084390A3 Histone deacetylase inhibitors
09/20/2007WO2007084319A3 Diaryl piperidines as cb1 modulators
09/20/2007WO2007071396A8 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions
09/20/2007WO2007041358A3 Substituted pyrazole compounds
09/20/2007WO2007035823A3 Partial mglur5 antagonists and methods of use thereof
09/20/2007WO2006017384A3 Indazoles useful in treating cardiovascular diseases
09/20/2007US20070219375 Novel Compound and Organic Electronic Device Using the Same
09/20/2007US20070219266 N-Acylated-3-(Benzoyl)-Pyrrolidines as 11-Beta-HSD1 Inhibitors Useful for the Treatment of Metabolic Disorders
09/20/2007US20070219257 Wnt Pathway Antagonists
09/20/2007US20070219252 Vla-R Antagonists
09/20/2007US20070219249 Diarylmethylidene Piperidine Derivatives, Preparations Thereof and Uses Thereof
09/20/2007US20070219244 Histone deacetylase inhibitors as therapeutics for neurological diseases
09/20/2007US20070219242 oxoquinoline derivatives such as 4-[3-carboxyethyl-1,4-dihydro-1-(4-fluorophenyl)methyl-4-oxoquinolin-6-yl]-2,4-dioxobutanoic acid, ethyl ester, used for preventing or treating acquired immunodeficiency syndrome (AIDS) infection
09/20/2007US20070219233 Substituted Indoles and Their Use as Integrin Antagonists
09/20/2007US20070219217 Triazolone Derivatives as Mmp Inhibitors for the Treatment of Asthma and Copd
09/20/2007US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both
09/20/2007US20070219210 Amidopyrazole Derivative
09/20/2007US20070219203 Arylalkylamino-substituted quinazoline analogues
09/20/2007US20070219197 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives
09/20/2007US20070219187 Allosteric Modulators of Metabotropic Glutamate Receptors
09/20/2007US20070219182 1H-2-Benzazepine-1,5(2H)-dione derivatives in which the N is connected via alkylene to a saturated or monounsaterated nitrogen heterocycle, e.g.,2-(3-{4-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl}propyl)-3,4-dihydro-1H-2-benzazepine-1,5(2H)-dione; dopamine-3 receptor modulators
09/20/2007US20070219179 Indole Derivative Having Piperidine Ring
09/20/2007US20070218136 New mandelic acid derivatives and their use as thrombin inhibitors
09/20/2007US20070218010 Contrast Agents for Magnetic Resonance Imaging
09/20/2007US20070215866 used in molecular scaled opto-electronic devices including field-effect transistors, light-emitting diodes and photovoltaic cells
09/20/2007CA2717242A1 Dibenzyl amine derivatives as cetp inhibitors
09/20/2007CA2647031A1 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
09/20/2007CA2646235A1 Non-peptidic renin inhibitors nitroderivatives
09/20/2007CA2646154A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases
09/20/2007CA2645712A1 Triazole derivative or salt thereof
09/20/2007CA2645711A1 Quinolone derivative or pharmaceutically acceptable salt thereof
09/20/2007CA2645376A1 Aminoquinolones as gsk-3 inhibitors